Patents by Inventor Kevin Keegen

Kevin Keegen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE
    Publication number: 20170140122
    Abstract: The present invention provides methods and compositions for monitoring of subjects suffering from, or being evaluated for, heart failure. A filtered Natriuretic peptide time-series, alone or in combination with other clinical indicia such as weight gain, can be used to estimate a patient's hazard (risk of decompensation). The cumulative integral of Natriuretic peptide concentration can be used to estimate cumulative hazard (risk times exposure) over longer periods of exposure, e.g., 14 day periods, or 30 day periods.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 18, 2017
    Inventors: Kenneth Kupfer, Richard C. Sangeorge, Jerome Mcaleer, Kevin Keegen, David Kinniburgh Lang
  • METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE
    Publication number: 20150169840
    Abstract: The present invention provides methods and compositions for monitoring of subjects suffering from, or being evaluated for, heart failure. A filtered Natriuretic peptide time-series, alone or in combination with other clinical indicia such as weight gain, can be used to estimate a patient's hazard (risk of decompensation). The cumulative integral of Natriuretic peptide concentration can be used to estimate cumulative hazard (risk times exposure) over longer periods of exposure, e.g., 14 day periods, or 30 day periods.
    Type: Application
    Filed: August 3, 2012
    Publication date: June 18, 2015
    Applicant: Alere San Diego, Inc.
    Inventors: Kenneth Kupfer, Richard C. Sangeorge, Jerome Mcaleer, Kevin Keegen, David Kinniburgh Lang